Notable Facts
→Partner at Venrock Healthcare Capital Partners (NOT CRV as specified in query)
→Co-founder and Board Director of Apogee Therapeutics
→Focuses on small-cap public biotechnology companies and crossover-stage investments
→Has been investing in healthcare since 2010, joined Venrock in 2013
→Previously worked as Research Analyst at Citadel LLC
→Holds BS in Pharmacy from Rutgers, MBA from Columbia Business School, MPH from Columbia
→Early investor in Biohaven (creators of Nurtec migraine drug)
→Member of Columbia Business School Healthcare Advisory Board